Mega Millions For Intercept Pharmaceuticals Shareholders. What's Next?

Jan 11 2014, 11:31am CST | by

When thinking of mega millions winners, we usually think of people who purchased lucky lottery tickets. This week, we should count as mega millions winners another category: investors who purchased shares in a small biotechnology company, Intercept Pharmaceuticals, Inc., before the closing of Wall Street on Wednesday — at around $72 or better at the 52wk low of $30.38.

The stock climbed to $275.87 on Thursday, and to $497 during the trading time on Friday, valuing the company close to $9 billion.

Now, think of the company insiders who held roughly 43 percent of the 13.4m of outstanding shares; the institutions, who held another 26 percent; and the individuals who held a few thousand before Thursday.

You can do the math.

The catalyst for these astronomical gains? The company’s liver-disease drug, which performed unexpectedly well in a clinical trial.

“The drug, called obeticholic acid, or OCA, mimics a naturally occurring human bile acid that Intercept believes has liver-protective properties,” writes Peter Loftus of Wall Street Journal.

But does the potential market for the drug justify the company’s current valuation?

ICPT key statistics

Market cap (intraday) 8.73B
Shares Outstanding 19.34M
%Held by insiders 42.7%
%Held by institutions 26.10%
Revenue 1.62M
Operating Cash Flow -21.87M

Source:Yahoo.Finance.com1/10/14

Obviously, investors buying shares on Friday believe so. I would be skeptical, however, for a number of reasons:

First, we are talking about a drug that performed well in a statistical trial, not a drug that has already received FDA approval. “Many experimental drugs fail to make it to the market, so Intercept’s OCA could stumble,” continues Peter Loftus. “But the clinical trial outcome raised investors’ expectations that the company could have a big-selling product on hands.”

Second, even if OCA receives an expedient FDA approval, marketing success is no guarantee. Investors have to look no further than the fate of Dendreon’s drug PROVENGE that received FDA approval a few years ago.

Third, even if OCA passes both the FDA and the market test, at the current market valuation, the company is valued at 10 percent of the value of Amgen Inc., which has been around for more than three decades and has several blockbuster stocks in the market.

Investors who have been around Wall Street long enough remember EntreMed Inc, another biotechnology company that displayed a similar performance in a short period. We all know what happened in that case.

Source: Forbes Business

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Global entrepreneurship summit boost for SMEs
Marrakech, Nov 22 (IANS) Nine agreements were signed between the Moroccan General Confederation of Enterprises (CGEM) and several small and medium enterprises (SMEs) as well as between major Moroccan banks and start-ups at the 5th Global Entrepreneurship Summit (GES 2014) held in Morocco.
 
 
NASA's flying saucer among 'Best of What's New'
Washington, Nov 22 (IANS) NASA's Low-Density Supersonic Decelerator (LDSD), a spacecraft that aims to facilitate the safe landing of future Mars missions, has earned a place in the the Popular Science magazine's "Best Of What's New" list.
 
 
Indian helping to light up Gambia (Diaspora Feature)
Banjul (Gambia), Nov 22 (IANS) Like many Indians who are proving to be philanthropists around Africa, Ram Mohan has set up a social business called Comafrique Intelizon Initiative and has embarked on the replacement of candles in villages in the Gambia with solar lights from India.
 
 
Leopards in human areas not conflict animals: Study
New Delhi, Nov 22 (IANS) Leopards in human areas are not always "stray" or "conflict" animals but residents with strategies to thrive in human dominated areas, says the first GPS-based study of leopards in India.
 
 
 

Latest from the Network

Davis Cup final: Switzerland nudges ahead with doubles win
Lille, Nov 23 (IANS/EFE) Superstar Swiss duo of Roger Federer and Stanislas Wawrinka put their country ahead in the Davis Cup final with a 6-3, 7-5, 6-4 victory over the French pair of Richard Gasquet and Julien...
Read more on Sport Balla
 
Former police official arrested over students' disappearance in Mexico
Mexico City, Nov 23 (IANS/EFE) A former deputy police chief and suspected member of the Guerreros Unidos ("United Warriors") drug cartel, that allegedly, is involved in the disappearance of 43 students in Mexico...
Read more on Politics Balla
 
Iran to allow UN inspectors access to Marivan nuclear site
Tehran, Nov 23 (IANS) Iran decided to allow UN nuclear inspectors access to its Marivan nuclear site, Atomic Energy Organisation of Iran (AEOI) said Saturday. "We are ready to provide a controlled access to the...
Read more on Politics Balla
 
Kendall Jenner feels she is like Hannah Montana
Los Angeles, Nov 23 (IANS) Model Kendall Jenner, who is seen in a reality TV show "Kourtney and Khloé Take The Hamptons", says she feels "like Hannah Montana" while juggling between fashion and TV. Hannah Montana,...
Read more on Celebrity Balla
 
Iran nuclear issue: Kerry holds talks with Gulf foreign ministers
Vienna, Nov 23 (IANS) US Secretary of State John Kerry held talks with the foreign ministers of UAE, Kuwait, Qatar and Bahrain on the Iranian nuclear issue Saturday. Earlier, Kerry delayed his departure from Vienna in...
Read more on Politics Balla
 
Professor Green not ready for kids
Professor Green and Millie Mackintosh are not ready to have children. The 30-year-old rapper - who is married to the former 'Made in Chelsea' star - has revealed they do not want to have a baby yet because their dogs...
Read more on Celebrity Balla
 
Taylor Swift's midriff mystery
Taylor Swift doesn't want people to know she has a belly button. The 'Blank Space' hitmaker admitted she chooses not to wear tops which reveal her midriff because she wants to keep her fans guessing as to whether she...
Read more on Celebrity Balla
 
Wilko Johnson: 'I shouldn't be here'
Wilko Johnson believes he ''shouldn't be here'' after battling cancer. The 'Game of Thrones' actor was given the all clear in October following a 17-month battle with pancreatic cancer, and has recalled the ''marvellous...
Read more on Celebrity Balla
 
Penelope Cruz joins Ben Stiller in 'Zoolander 2'
Los Angeles, Nov 23 (IANS) Actress Penelope Cruz is all set to star with actor Ben Stiller in the film "Zoolander 2". According to Deadline magazine, details of Cruz's role in the sequel of "Zoolander" has not been...
Read more on Celebrity Balla
 
No general election in Pakistan before 2018: Nawaz Sharif
Islamabad, Nov 23 (IANS) Pakistan Prime Minister Nawaz Sharif said Saturday that a general election would not be held in the country before 2018. He thus rejected the demands by the opposition Pakistan Tehreek-i-Insaf...
Read more on Politics Balla